STAT+: Roche gets a lung cancer win with its KRAS drug divarasib
One of the more impressive data sets at this year’s ESMO came from a Roche study of its drug divarasib, which treats lung cancer.
Read at STAT News · 26 October 2026 at 23:17
STAT+: Roche gets a lung cancer win with its KRAS drug divarasib
All coverage of this event, automatically grouped from multiple independent sources.
Last updated: 27 October 2026 at 01:31 · 7 articles · 1 sources
STAT+: Nonprofit Bon Secours Mercy Health strikes $5.7 billion deal for surgery center chain
The deal would make the Catholic system one of the largest operators of outpatient surgery centers.
Read at STAT News · 26 October 2026 at 21:54
STAT+: HHS relaxes security, transparency rules for health record software used by hospitals
The Trump administration removed several security, privacy and transparency requirements for vendors of EHR software.
Read at STAT News · 26 October 2026 at 21:16
STAT+: House lawmaker probes PBMs for ‘punitive’ audits of independent pharmacies
A House lawmaker is investigating whether the three largest PMS targeted independent pharmacies withretaliatory audits.
Read at STAT News · 26 October 2026 at 16:26
STAT+: GSK sees its return to cancer start to pay off
A decade ago, GSK was out of oncology. It could soon pick up approval for its sixth cancer drug.
Read at STAT News · 26 October 2026 at 16:20
STAT+: Merck ADC drug cut risk of death by one-third in advanced endometrial cancer
A Phase 3 trial of a targeted drug developed by Merck and China’s Kelun-Biotech cut by one-third the risk of death in patients with advanced endometrial cancer.
Read at STAT News · 26 October 2026 at 15:30
STAT+: Rising premiums, a sad Medicaid gathering, and a new fraud crackdown
The cost of health insurance is surging, and CMS presses ahead with a new fraud crackdown.
Read at STAT News · 26 October 2026 at 14:38